The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112798693 11279869 3 F 20160831 20150717 20160906 EXP US-PFIZER INC-2015234595 PFIZER 60.00 YR F Y 68.00000 KG 20160906 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112798693 11279869 1 PS LYRICA PREGABALIN 1 Oral 225 MG, 1X/DAY 21446 225 MG CAPSULE, HARD QD
112798693 11279869 2 SS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY N17632 21446 150 MG CAPSULE, HARD BID
112798693 11279869 3 SS LYRICA PREGABALIN 1 Oral 150 MG, 3X/DAY 21446 150 MG CAPSULE, HARD TID
112798693 11279869 4 C SINGULAIR MONTELUKAST SODIUM 1 10 MG, 1X/DAY 0 10 MG QD
112798693 11279869 5 C DULERA FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE 1 1 PUFF (FORMOTEROL FUMARATE 5 MCG / MOMETASONE FUROATE 100 MCG), 2X/DAY 0 BID
112798693 11279869 6 C ATENOLOL/CHLORTHALIDONE ATENOLOLCHLORTHALIDONE 1 100-25MG TABLET ONCE A DAY 0 TABLET QD
112798693 11279869 7 C SERTRALINE SERTRALINE HYDROCHLORIDE 1 50 MG, 2X/DAY 0 50 MG TABLET BID
112798693 11279869 8 C ATORVASTATIN ATORVASTATIN 1 40 MG, 1X/DAY 0 40 MG TABLET QD
112798693 11279869 9 C MONTELUKAST MONTELUKAST SODIUM 1 10 MG, 1X/DAY 0 10 MG TABLET QD
112798693 11279869 10 C OMEPRAZOLE. OMEPRAZOLE 1 40 MG, 1X/DAY 0 40 MG CAPSULE QD
112798693 11279869 11 C ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 100 MG, 1X/DAY 0 100 MG TABLET QD
112798693 11279869 12 C CLONAZEPAM. CLONAZEPAM 1 0.5 MG, 1X/DAY 0 .5 MG CAPSULE QD
112798693 11279869 13 C METHOCARBAMOL. METHOCARBAMOL 1 750 MG, 3X/DAY 0 750 MG TABLET TID
112798693 11279869 14 C METHOCARBAMOL. METHOCARBAMOL 1 0 TABLET
112798693 11279869 15 C HYDROCODONE/ACETAMINOPHEN 5 2 1 DF, AS NEEDED (ONE TABLET EVERY EIGHT HOURS) 0 1 DF TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112798693 11279869 1 Fibromyalgia
112798693 11279869 2 Pain
112798693 11279869 4 Hypersensitivity
112798693 11279869 5 Asthma
112798693 11279869 6 Blood pressure abnormal
112798693 11279869 7 Anxiety
112798693 11279869 8 Blood cholesterol abnormal
112798693 11279869 9 Hypersensitivity
112798693 11279869 10 Reflux gastritis
112798693 11279869 11 Insomnia
112798693 11279869 12 Anxiety
112798693 11279869 13 Muscle relaxant therapy
112798693 11279869 14 Pain
112798693 11279869 15 Pain

Outcome of event

Event ID CASEID OUTC COD
112798693 11279869 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
112798693 11279869 Cataract
112798693 11279869 Drug effect incomplete
112798693 11279869 Night blindness
112798693 11279869 Pain
112798693 11279869 Visual acuity reduced

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112798693 11279869 5 2008 0
112798693 11279869 6 2011 0
112798693 11279869 13 2016 0
112798693 11279869 15 20160531 0